These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32663194)

  • 1. Polycystin-1 regulates ARHGAP35-dependent centrosomal RhoA activation and ROCK signaling.
    Streets AJ; Prosseda PP; Ong AC
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32663194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilia and polycystic kidney disease.
    Ma M
    Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.
    Porath B; Livingston S; Andres EL; Petrie AM; Wright JC; Woo AE; Carlton CG; Baybutt R; Vanden Heuvel GB
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1050-F1059. PubMed ID: 28701314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of polycystins suppresses deciliation via the activation of the centrosomal integrity pathway.
    Gerakopoulos V; Ngo P; Tsiokas L
    Life Sci Alliance; 2020 Sep; 3(9):. PubMed ID: 32651191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway.
    Hartman TR; Liu D; Zilfou JT; Robb V; Morrison T; Watnick T; Henske EP
    Hum Mol Genet; 2009 Jan; 18(1):151-63. PubMed ID: 18845692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
    Harris PC
    Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 8. XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice.
    Krappitz M; Bhardwaj R; Dong K; Staudner T; Yilmaz DE; Pioppini C; Westergerling P; Ruemmele D; Hollmann T; Nguyen TA; Cai Y; Gallagher AR; Somlo S; Fedeles S
    J Am Soc Nephrol; 2023 Jan; 34(1):110-121. PubMed ID: 36270750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myc is a regulator of the PKD1 gene and PC1-induced pathogenesis.
    Parrot C; Kurbegovic A; Yao G; Couillard M; Côté O; Trudel M
    Hum Mol Genet; 2019 Mar; 28(5):751-763. PubMed ID: 30388220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent function of polycystin 1 and polycystin 2 in cell size regulation.
    Viau A; Kotsis F; Boehlke C; Braeg S; Klein M; Nitschke R; Walz G; Kuehn EW
    Biochem Biophys Res Commun; 2020 Jan; 521(2):290-295. PubMed ID: 31668373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular advances in autosomal dominant polycystic kidney disease.
    Gallagher AR; Germino GG; Somlo S
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):118-30. PubMed ID: 20219615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Mechanisms of ADPKD.
    Kim DY; Park JH
    Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
    Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Autonomous Hedgehog Signaling Is Not Required for Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ma M; Legué E; Tian X; Somlo S; Liem KF
    J Am Soc Nephrol; 2019 Nov; 30(11):2103-2111. PubMed ID: 31451534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
    Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
    Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease.
    Cai J; Song X; Wang W; Watnick T; Pei Y; Qian F; Pan D
    Genes Dev; 2018 Jun; 32(11-12):781-793. PubMed ID: 29891559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
    Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
    Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus.
    Ha K; Nobuhara M; Wang Q; Walker RV; Qian F; Schartner C; Cao E; Delling M
    Elife; 2020 Nov; 9():. PubMed ID: 33164752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic kidney disease: a Hippo connection.
    Ma S; Guan KL
    Genes Dev; 2018 Jun; 32(11-12):737-739. PubMed ID: 29921661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice.
    Ahrabi AK; Terryn S; Valenti G; Caron N; Serradeil-Le Gal C; Raufaste D; Nielsen S; Horie S; Verbavatz JM; Devuyst O
    J Am Soc Nephrol; 2007 Jun; 18(6):1740-53. PubMed ID: 17475819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.